Related Experiment Videos
Signet ring cell carcinoma in the prostate.
A Kendall1, C M Corbishley, H S Pandha
1Department of Oncology, St George's Hospital Medical School, London, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|April 13, 2004
Summary
Prostate metastases are rare, usually indicating widespread cancer. This case highlights an unusual instance of primary gastric signet ring cell adenocarcinoma presenting as prostate metastases over a year after initial treatment.
Area of Science:
- Oncology
- Gastroenterology
- Urology
Background:
- Metastases to the prostate gland are uncommon, typically associated with advanced or widespread malignant conditions.
- Gastric adenocarcinoma, particularly the signet ring cell subtype, is known for its aggressive nature and potential for diverse metastatic patterns.
Observation:
- This report details an unusual clinical presentation where a patient was diagnosed with metastatic disease in the prostate.
- The primary malignancy was subsequently identified as gastric signet ring cell adenocarcinoma (SRCC).
Findings:
- The diagnosis of gastric SRCC was made more than one year after the initial detection and treatment of metastatic disease localized to the prostate.
- This temporal relationship challenges typical metastatic progression patterns.
Implications:
- This case underscores the importance of considering rare metastatic origins, even when the initial presentation suggests a more common pathway.
- It highlights the need for thorough diagnostic evaluation in cases of prostate metastases, irrespective of initial findings.
- Understanding unusual metastatic patterns of gastric cancer can inform clinical suspicion and diagnostic strategies.